. However, the sensitivity of the porcine sympathoadrenal system and little myocardial collateral supply (Shaper et al. 1967) , leading to sudden ventricular fibrillation, myocardial ischaemia and cardiac death, compromise heart catheterization in some strains of swine.
Recently, extensive studies have been demanded in well-understood animal systems to design more sophisticated stent devices (Schwartz &. Holmes 1994) . For this purpose, we provide a detailed description and discussion of an experimental set-up, allowing for safe intracoronary stenting with successful long-term follow-up in a porcine model.
Materials and methods

Animal preparation
So far, 24 pigs of the Suabian Hall strain of either sex with a body weight (bw) in the range of 40-70 kg (mean bw 54 ± 2 kg) obtained from a local supplier were used. All procedures and handling of the animals were performed in such a way to minimize discomfort and stress for the animals. Keeping of the animals, which adhered to the guidelines for the handling of animals set by the National Institute of Health and which had been approved by the German Committee of Animal Care, included housing in single boxes (1.5m x 2.0 m) at a temperature of 21 ± PC and a relative humidity of 62±4% with natural illumination. The animals were allowed free access to drinking water and a standard diet (Ein-Mast-Korn, Alleinfutter hir Mastschweine, Raiffeisen-Waren-Zentrale, Koln, Germany). After a 5-day adaptation period, food, but not water, was withdrawn 24h before the experiments. Neither antiplatelet nor anticoagulant therapies were performed prior to the experiments.
The animals were sedated with an intramuscular injection of azaperone (10mg/kg bWj Janssen, Neuss, Germany) and methomidate hydrochloride (Hypnodil, 10mg/kg bWj Janssen, Neuss, Germany). A transcutaneously inserted 20 G catheter (Venflon®2j Vollmar et al. Ohmeda, Helsingborg, Sweden) was placed in an ear vein for induction of anaesthesia with etomidate (1mg/kg bWiJanssen, Neuss, Germany). The animals were further given 0.05 mg/kg bw atropine intravenously to reduce salivation. Using a curved laryngoscope (Penlon, Mactintosh, UK!, the animals were then intubated with a tracheal tube (7.5mm ID, Portex, Hythe, Kent, England) and mechanically ventilated (Spiromat 656, Drager, Lubeck, Germany) with an oxygen/nitrous oxide mixture (1 :2 vol/vol). Initially high concentrations of isoflurane (2.0-2.5 vol%) in the inspired gas allowed the rapid induction of sufficient anaesthetic depth. End-tidal concentrations of the inhalation anaesthetic were measured by a multigas-analyzer (EMMA, Engstrom, Sweden). Blood gas analysis (ABL30autoanalyzer, Radiometer, Copenhagen, Denmark) were repetitively performed, and ventilation was set as necessary to maintain physiological conditions for P02, pH, and PC02, i.e. the inspiratory oxygen fraction (Fi02 0.21-0.30j Oxydig, Drager, Germany) was adjusted to keep arterial P02 above 1l0mmHg, and at a rate of 20 breaths per minute tidal volume was set to keep end-expiratory CO2 at 4.5vol% and arterial CO2 between 35 and 45 mmHg (Table 1) .Balanced anaesthesia was achieved throughout the experiment by intravenous infusion of piritramide (10mg x kg-1 x h-1 i Janssen, Neuss, Germany) and dihydrobenzperidole (0.01mg x kg-1 x h -], Janssen, Neuss, Germany) as well as by iso- 
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AP5yst =systolic arterial pressure; APd;.5t = diastolic arterial pressure; HR= heart rate; P.02 = arterial oxygen partial pressure; P.C02=arterial carbon dioxide partial pressure; means± SEM;n (number of animals) = 24 flurane in the inspired gas (1-2 vol%; Abboth, Wiesbaden, Germany). In pigs, 1.45 vol% isoflurane is reported as MAC (Eisele et al. 1985) . Throughout the experimental procedure, the monitoring of inspiratory airway pressure (BarologA, Drager, Lubeck, Germany) revealed values below 25 mmHg, and positive end-expiratory pressure was kept at 2 mmHg in order to prevent atelectasis and reduce the risk of pneumonic infection. The animals were placed in the supine position on the catheterization table, with rectal temperature maintained at 38°C by a heating pad. The right femoral area was shaved, prepared with povidone-iodide solution (Braun-Melsungen, Melsungen, Germany) and draped in a sterile fashion. Using the sterile thermocoagulation technique, a skin incision was made over the right femoral artery which was then isolated by blunt dissection, caudally ligated and cranially equipped with a vascular clamp so that a small arteriotomy could be performed. A 7F side arm introducer sheath (AD Krauth, Hamburg, Germany) was placed intravascularly, serving for haemodynamic monitoring via a Statham"l\ transducer (DTX/Plus Uo , Ohmeda, Erlangen, Germanyl, blood sampling and placement of several devices for intracoronary stenting. A blood specimen was then obtained for analysis of the activated coagulation time (ACT), serving as baseline value. Next, heparin (lSO-200IU/kg bwl was administered intravenously, and 15min thereafter activated coagulation time was re-assessed. Haemodynamic monitoring included the continuous recordingjdisplay of both limb-leaded electrocardiogram and arterial blood pressure (Hellige multichannel recorder, Servomed SMV 104, Hellige, Freiburg, GermanYi 'l-channel graph, 3021 Pen Recorder, Yokogawa Herrsching, Germany) ( Table 1) . Physiologic saline solution was infused at a rate of 5 ml x kg-1 x h-1 throughout the experiment. No antibiotic prophylaxis was administered.
Coronary stenting procedure Coronary arteriography was performed by using a 7F guiding catheter (Sherpa, Medtronic, Danvers, MA, USAi hockey-stick II, 193 III; AL I, SAL III which was advanced to the ascending aorta through the femoral arterial access. The guiding catheter was positioned selectively in the left anterior descending coronary artery (LAD, n = 12) and the left circumflex artery (LCx, n = 12), respectively.
By hand injection of 4 to 5 ml pre-warmed contrast medium (Ultravisr"'-370, Schering, Berlin, Germany), coronary arteriography was best performed in the anterior posterior projection with a 30-45°caudal angulation. X-ray exposure was made with a Philips BV'l'l angiography system using an image intensifier (MSP,Philips, Hamburg, Germany). Coronary angiograms were recorded in video format (S-VHS,Panasonic AG 7350, Matsushita, Tokyo, Japan). Intracoronary nitroglycerin, 100 to 200 figwas administered immediately before the stent implantation. A 0.014-inch (~0.35mm) guide wire was then steered down the LAD or LCx, respectively. The vessel diameter was obtained by realtime intravascular ultrasonography (Sonos Intravascular M'l40017, Hewlett Packard, Mountain View, CA, USAI which was provided by a 3.5F, 30 MHz imaging element (Sonicath CV, Mansfield, Watertown, MA, USA) and passed along the guide wire in a monorail technique at the selected sites (proximal/mid/distal) of stent expansion. At each site, topographic views were recorded and stored. At the mid position of the selected site of the stent, the vessel diameter was assessed and used as a reference for the subsequent sizing of the angioplasty catheter. An appropriate balloon angioplasty catheter [3.0mm for 'l.5-mm and 3.5 mm for 3.G-mm coronary segments; Asuka, Schneider, Bulach, Switzerland) with the stent coil gently compressed and crimped on its deflated balloon was then advanced over the guide wire to the site pre-selected for implantation. The stem was deployed at this site by the inflation of the balloon catheter to 5-lOatm for 10 s twice. The appropriate pressure was chosen with regard to the vessel diameter and in order to achieve a 10% oversizing. The balloon catheter was then deflated and withdrawn along the guidewire. 200 fig nitroglycerin was again administered intracoronary, and coronary angiography was repeated. Additional doses of nitroglycerin were given if significant coronary spasm was observed.
Before stent implantation, coronary blood flow velocity was measured using a 0.018inch (~0.46 mm) flow wire equipped with a piezoelectric ultrasonic Doppler probe (Flo-MapQlI; Cardiometries, Mountain View, CA, USA). The position of the wire was adjusted to obtain a maximum physical signal, which was recorded distal to the selected site of stent implantation, where the adenosineinduced coronary response was repeated after the stenting procedure.
After repeat angiography of the stented coronary arteries, the guiding catheters and the introduced sheath were removed, and the arteriotomy was repaired (5.0 vicryl; Ethicon, Norderstedt, Germany). Alternatively, the femoral artery was ligated. The incision was then closed in two layers with 3-0 vicryl (Ethicon, Norderstedt, Germany) deep subcutaneously and with subcuticular sutures. Antiseptic spraying plaster (Nobecutan®, Wedel, Germany) was applied topically to the shaved area at the end of the procedure. In none of the animals did wound infection or ischaemic injury of the hind-leg occur.
Anaesthesia was finished by the elimination of isoflurane and nitrous oxide from the inspired gas. Animals were then ventilated with an oxygen/air mixture for at least 10min. For stimulation of the breathing centre, moderate hypercapnia was induced by lowering the ventilatory rate and tidal volume. Perioperative mortality was zero and all (24) animals rapidly awoke from anaesthesia and were allowed to recover in individual boxes under close observation. Since our study aimed to evaluate stent surface characteristics in vivo, no post-procedure antithrombotic drugs were administered, as this would have resulted in a considerably high incidence of post-operative sudden heart attack due to coronary thrombosis.
Follow-up protocol after stenting
In 11 animals, early death occurred within the first 6 h after the stent implantation due to occlusive thrombi as examined by postmortem histology. There was no mortality beyond 12h after the stenting procedure. The remaining animals tolerated the procedure well and showed no signs of discomfort. In particular, no effects on sleeping and feeding habits were observed. Accordingly, weight gain within 6 months was 166%, with a mean body weight of 89 ± 17kg after 6 months. The remaining 13 animals were restudied at either 2 weeks In = 2), 4 weeks (n = 2), 6 weeks In = 21or 6 months (n = 7).
For follow-up angiography, the pre-anaesthesia and anaesthesia protocols as well as the catheterization procedure were identical to those described above, including coronary angiography and NUS as well as the determination of coronary flow by flow-wires. Catheterization was performed via the right carotid artery using a 7F vascular sheath. Video recording was obtained in the same projection as utilized in the initial procedure. Thereafter, the thorax was opened and, after euthanasia with an overdose of anaesthesia, the hearts were excised in toto and fixed in 10% formaldehyde for subsequent light microscopic investigations of coronary artery speCimens.
Discussion
In the field of interventional cardiology, intracoronary stenting improved the success rate of angioplasty and promised limited re-stenosis rates due to the larger post-procedure lumen. However, two major obstacles, subacute thrombosis and intimal hyperplasia, have still to be overcome. A solution to these problems would be an anti thrombotic and anti proliferative device requiring no anticoagulation and with the simultaneous prevention of subacute closure and re-stenosis. Thus, emphasis must be placed on the development and test of these new devices in appropriate animal models.
Although it is still debated as to which animal model best approximates the human response to stenting, in several respects the porcine model is advantageous over others for testing stent patency: 11)the coronary anatomy and dimensions of swine of 40-70 kg approximate that of humans (French et al. 1965 , Fritz et al. 1980 , White & Bloor 1981 , Fuster et al. 1982 , Lee 1986 ); (2)in porcine myocardium there is rare collateral blood supply, similarly as seen in healthy humans (Lumb et al. 1962 , Harken et al. 1981 , White & Bloor 1981 ; (3) it has been noted that the platelets and coagulation system of swine are similar to those of humans (Bowie et al. 1973 , Fuster et al. 1982 , Lam et al. 1987 , Badimon et al. 1988 )and that pigs resemble the human situation in terms of tendency I disposition of neointimal hyperplasia formation (Schwartz & Holmes 1994) .
One significant limitation might be that the intact swine coronary artery with normal intima is not necessarily comparable to the diseased human coronary artery and may be more forgiving of mechanical intervention, with a reduced risk of stent thrombosis. On the other hand, however, this drawback can be conquered by overexpansion of the vessel (medial rupture I during stent implantation.
Such an overexpansion, which has also been suggested for stent implantation in humans (Moussa et al. 1996) ,is in fact desirable as it fixes the stent within the vessel and prevents its migration. Pathological studies indicate that the intimal smooth muscle cell proliferation seen in human re-stenosis is associated predominantly with the nonatheromatous portion of the vessel wall (Gravanis & Roubin 1989) .Thus, although the absence of atherosclerosis in the animal model presented herein may lead to mechanical properties that are different from those in hUlnans with obstructive atherosclerotic vascular disease, the histologic similarities should permit the use of healthy, normolipaemic pigs for the study of stent patency and neointimal formation, with the above limitations.
Beside the species, the strain used must be taken into consideration. A suitable model for intra coronary stenting must employ swine of a strain which are inexpensive, readily available and-of particular importance-easy to handle. This includes a low sensitivity of the sympathoadrenal system in order to avoid sudden ventricular fibrillation, myocardial ischaemia, and cardiac death during the heart catheterization procedure. In all these respects, normolipaemic Suabian Hall pigs appear to be superior to other special varieties suggested in previous studies (Fuster et al. 1982 , van der Giessen et al. 1991 , White et al. 1992 .We advocate this 195 strain of swine since coronary spasm occurs far less frequently than in other strains of swine, where any foreign body within the arterial lumen significantly enhances vasomotor tone, thereby affecting the outcome of the experiments (Biiret al. 1991) .Although it has been assumed that coronary spasm distal to the stent is a potential mechanism of vessel closure, spasm after stent implantation has been described in only a few human cases (Sigwart et al. 1988 , Schatz 1989 ). Thus, the Suabian Hall pigs, with lower propensity for spasm than pigs of other strains, would certainly be advantageous. In fact, in our experience with 24 animals perioperative mortality was zero and neither alterations of haemodynamics nor complications due to ventricular fibrillation or coronary spasm were observed.
The procedure of intra coronary stenting in swine approximates the clinical situation except the need for anaesthesia. If one considers the proposed mechanisms of general anaesthesia, i.e. decrease of synaptic transmission and impulse propagation by the inhibition of transmembraneous ion flux, it becomes evident that these effects can cause profound alterations in all other organ systems beside the central nervous system. This includes the cardiovascular system, which is most susceptible to cardiac rythmic and myocardial depressive effects due to its rich autonomic innervation and the unique properties of myocardial cells (conduction, contraction). A balance of sympathetic and parasympathetic input is required in order to maintain normal cardiac and peripheral vascular function, finally determining oxygen balance of the myocardium. It has been postulated that inhalation anaesthetics may have some protective effects by attenuating coronary artery 'vasospasm', and by diminishing ischaemia-induced myocardial damage due both to improved tolerance to tachycardia and hypoxia and to some antiarrhythmogenic effects (Hobbhahn et al. 1993 ). However, there is evidence that catecholamine release during surgical stress is more suppressed, if inhalation anaesthetics are used together with narcotics (Tandonnet et al. 1991) .This makes the combination of narcotics and inhalation anaesthetics, such as isoflurane, the most appropriate approach for anaesthesia, particularly in view of the fact that a narcotic regimen alone, i.e. without an inhalational agent, does not block sympathetic response to surgical stress and cardiac interventions (Hobbhahn et a1. 1993) . Beside the need for mechanical ventilation for the application of the volatile anaesthetic, ventilation allows the adjustment of physiologic blood gas conditions and, thus, the elimination of adverse effects of hypoxia, hypo-and hypercapnia on myocardial blood flow and oxygenation (Habazettl et a1. 1990) .
The chosen balanced anaesthetic regimen, i.e. the use of an inhalation agent in combination with intravenously applied narcotics and analgesics, is widely used in experimental porcine models (Vollmar et a1. 1993) and is advantageous to monoanaesthetic regimens in respect to the animals' haemodynamic stability, excellent control of anaesthetic depth, rapid awakening and recovery of physiologic functions, similarly as observed in humans IPandit & Green 1994).In addition, additive effects of different anaesthetics allow the required amount of each substance to be minimized, thereby reducing potential side effects. Comparing the commercially available and commonly used inhalation agents halothane, enflurane and isoflurane, the latter seems to be superior in several respects: isoflurane differs from halothane, which is reported to alter platelet function dose dependently in those concentrations commonly used (Gibbs 1991) . Beside the antithrombotic effect, halothane, but not isoflurane, increases bleeding time and alters platelet deposition on artificial arterial grafts (Gibbs 1991) , thereby potentially influencing stent patency. In contrast to halothane, isoflurane does not trigger malignant hyperthermia in swine (Roewer et a1. 1995) . In addition, isoflurane preserves coronary reserve (Gilbert et 01. 1988 )and does not depress myocardial contractility to the same extent as halothane or enflurane, if at all (Conzen et 01. 1989). To minimize cardiodepressant agents, anaesthesia is induced/maintained with neuroleptic azaperone and droperidole, an C(2-adrenergic agonist (metomidatel and an opioid (piritramide), which have relatively little influence on Vollmar et al. cardiovascular performance in comparison to barbiturates (Orr et a1. 1976 , Buttner et a1. 1990 , Roewer et a1. 1995 . Nitrous oxide is also a common inhaled anaesthetic routinely used as a component of general anaesthesia in animals and men. Its safe use, even in patients with coronary artery disease, is well documented (Cahalan et a1. 1987 , Slavik et a1. 1988 , Mitchell et a1. 1989 ).Moreover, intravital microscopic studies in the canine heart demonstrated that nitrous oxide neither influences coronary arteriolar tone nor reduces or redistributes myocardial blood flow (Vollmar et 01. 1995) . Thus, its use in a model of intracoronary stenting in pigs seems unquestionable.
For the assessment of anaesthetic depth (Roewer et a1. 19951 as well as for the documentation of cardiac intervention-induced arrythmias or ST segment elevations (Bar et 01. 1991) haemodynamic monitoring, including continuous recording/display of limb-leaded electrocardiogram and of arterial blood pressure, as well as repetitive blood gas analysis are compelling.
Vascular access for coronary angiography and stent implantation should be achieved via blunt dissection and arteriotomy of the right femoral artery vessel and not-in contrast to the clinical practice-via percutaneous puncture of the vessel. The risk of bleeding, dissection as well as formation of pseudoaneurysms or arteria-venous fistula is at least as high as that observed in patients (Schomig et a1. 1994) or even higher and might require surgical correction. Alternatively, the right carotid artery is chosen for the arterial access allowing a comparably easy intubation of the coronary artery system.
Anticoagulation strategies and antiplatelet regimens are major determinants of stent patency and should thus be carefully chosen within an experimental set-up for the testing of intracoronary stents. In pigs, sudden death, typically occurring within the first 6 h following stent placement, is known to be fairly high (~50%), when only a single bolus of intravenous heparin (300U/kg body weight) is applied (Schwartz et 01. 1990 ). However, this rate can readily be reduced simply by premedication with 650 mg aspirin at least 24h before stent implantation (Schwartz et al. 1990) underlining the importance of anticoagulation therapies. For testing novel low or non-thrombogenic stent designs and coatings, we feel that implantation conditions should be deliberately made difficult by withholding antithrombotic drugs, anticoagulants, dextran, or antiplatelet aggregation therapies, except for heparin during the implantation procedure.
To achieve successful deployment of intracoronary protheses, the use of intravascular ultrasonography (IVUS) is recommended and is reportedly superior to angiography. Both angiography and IVUS provide information regarding the choice of site for placement of the device and sizing the coronary lumen. However, in contrast.to angiography, IVUS displays tomographic views of the vessel anatomy, enables determination of crosssectional areas, allows for assessment of full stent expansion, and provides information in terms of surface topography along the length of the devices, which is of particular relevance at re-examination of stent patency. In a canine study with infrarenal protheses, White and co-workers (1995) reported that several critical observations, such as incomplete stent expansion, were detectable only by IVUS and led to further interventions at the time of deployment. In our study, it was also documented that lumenal continuity and areas of irregularity, thrombus, or narrowing are assessed more sensitively by IVUS than by angiography or ultrafast computed tomography (White et al. 1995) .
Measurement of coronary blood flow under conditions of maximal coronary vasodilation serves as a highly sensitive indicator of the quality of myocardial perfusion, and coronary flow reserve is considered a good physiological index of myocardial vasodilator responsiveness, both in animals and in humans (Tauchert & Hilger 1979 , Hoffman 1984 , Cohen 1986 , Conzen et al. 1992 , Habazettl et al. 1994 . Although coronary vascular reserve is measured in humans to assess the physiological significance of coronary stenoses (Hoffman 1984L the effects of stent placement on this index of coronary function have not been thoroughly investigated yet (Haude et al. 1996 , Versaci et al. 1996 . This experi-197 mental set-up includes the assessment of coronary vascular reactivity (coronary flow reserve) prior to and after stent implantation. Coronary reserve, i.e. the capacity of the coronary circulation to increase blood flow during maximal coronary vasodilation, is usually produced pharmacologically. Thus, it is defined as the vascular response to the intra coronary application of adenosine and is calculated as the ratio of average peak velocity of coronary blood flow to resting average peak velocity. Coronary blood flow velocity typically increases markedly upon application of adenosine (200 flg bolus injection), then returns to baseline within 1-2 min. Thus, combined application of flow wire and real-time intravascular ultrasonography enables the determination of coronary blood flow velocity and coronary flow reserve as well as the assessment of coronary vessel anatomy and cross-sectional areas. At reexamination after distinct time intervals, the use of these measures provides detailed information about the effect of stent implants on coronary haemodynamics, vascular tone and vessel surface, and about the topography of the stent, as well as the continuous process of stent entrapment by neointimal proliferative tissue with lumenal narrowing and the re-stenosis properties.
Regarding these aspects, the authors like to call the present porcine model as an ideal experimental set-up not only for the test of novel, intracoronary stent devices, but also for the study of adjuvant therapeutic strategies, such as (i) inhibition of neointimal proliferation by a protein adduct of nitric oxide (Marks et al. 1995) or an endothelin receptor antagonist (Ferrer et al. 1995) ; (ii) endovascular irradiation via low-dose radioactive stents (Hehrlein et al. 1995) ; and (iiil acceleration of stent endothelialization by local delivery of growth factors (Van Belle et al. 1997 Hobbhahn J, Goetz AE, et al. (19891 Myocardial contractility, blood flow, and oxygen consumption in healthy dogs during anesthesia with isoflurane or enflurane. 
